INFLUENCE OF TROUGH SERUM LEVELS AND IMMUNOGENICITY ON LONG-TERM OUTCOME OF INFLIXIMAB THERAPY IN ULCERATIVE COLITIS

(1) UZ Leuven



This item was part of the IBD II session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A303